A contemporary review of Clostridioides difficile infections in patients with haematologic diseases

• Published in: Journal of internal medicine Vol. 289; no. 3; pp. 293 - 308
• Main Authors: Dutta, D., Jafri, F., Stuhr, D., Knoll, B. M., Lim, S. H.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.03.2021
• Subjects: Antibiotics; Antiinfectives and antibacterials; Antimicrobial agents; Antimicrobial peptides; C. difficile infection; Chemoradiotherapy; Diseases; haematologic diseases; Health risks; Immunosuppression; Immunotherapy; Infections; intestinal dysbiosis; Microbiomes; Microbiota; Morbidity; Opioids; Peptides; Probiotics; Proton pump inhibitors; Risk analysis; Risk factors; Transplantation; Virulence; intestinal dysbiosis; C. difficile infection; haematologic diseases

Clostridioides (Clostridium) difficile (C. difficile) infection is one of the most common causes of increased morbidity and mortality. Approximately 500 000 C. difficile infections (CDIs) occur each year in the United States, and they result in more than 29 000 deaths. Patients with haematologic dis...